# Prevalence and Clinical Course of Chronic Hep B Infection in IBD and Rheumatologic Disease

> **NCT02128503** · NA · TERMINATED · sponsor: **Chinese University of Hong Kong** · enrollment: 430 (actual)

## Conditions studied

- Inflammatory Bowel Disease
- Crohn Disease
- Ulcerative Colitis
- Rheumatic Diseases
- Hepatitis B, Chronic

## Interventions

- **OTHER:** HBV DNA level monitoring

## Key facts

- **NCT ID:** NCT02128503
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-02
- **Primary completion:** 2015-10-16
- **Final completion:** 2015-10-16
- **Target enrollment:** 430 (ACTUAL)
- **Why stopped:** sample size recruited is not enough
- **Last updated:** 2017-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02128503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02128503, "Prevalence and Clinical Course of Chronic Hep B Infection in IBD and Rheumatologic Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02128503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*